Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DATA-INSIGHT: Data Analysis for Treatment Assessment and Evaluation of New Sources for Evidence Generation in German Healthcare System

NCT07308639 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT07308639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07308639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DATA-INSIGHT: Data Analysis for Treatment Assessment and Evaluation of New Sources for Evidence Generation in German Healthcare System
Lead sponsor
Bayer
Phase
Observational
Overall status
Recruiting
Start date
March 3, 2026
Completion date
December 31, 2026
Enrollment
50,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neovascular age-related macular degeneration (namd), diabetic macular edema (dme), retinal vein occlusion (rvo)